Sign Up to like & get
recommendations!
0
Published in 2024 at "Advanced Science"
DOI: 10.1002/advs.202400702
Abstract: The programmed death 1 (PD‐1)/programmed death ligand 1 (PD‐L1) axis inhibits T cell activity, impairing anti‐tumor immunity. Blocking this axis with therapeutic antibodies is one of the most promising anti‐tumor immunotherapies. It has long been…
read more here.
Keywords:
blockade;
spatial distribution;
cell identity;
identity spatial ... See more keywords